GU Cancers 2020 | Potential prognostic markers in sarcomatoid and rhabdoid RCC

Name: Potential prognostic markers in sarcomatoid and rhabdoid RCC
Uploaded: 2020-02-13T00:00:00.000Z
Duration: 4 min 49 s
Description: Ziad Bakouny, MD, Dana-Farber Cancer Institute, Boston, MA, discusses the genomic characterization of sarcomatoid and rhabdoid renal cell carcinoma (RCC) to reveal potential markers of poor prognosis and response to immune checkpoint inhibition. This interview took place at the 2020 Genitourinary Cancers Symposium, held in San Francisco, CA.

Ziad Bakouny • 13 Feb 2020

GU Cancers 2020

Genitourinary Cancer Kidney Cancer Antibodies Checkpoint Inhibitors Nivolumab

Ziad Bakouny, MD, Dana-Farber Cancer Institute, Boston, MA, discusses the genomic characterization of sarcomatoid and rhabdoid renal cell carcinoma (RCC) to reveal potential markers of poor prognosis and response to immune checkpoint inhibition. This interview took place at the 2020 Genitourinary Cancers Symposium, held in San Francisco, CA.